Continent;DRC;Site Name;Latitude;Longitude;Site Name/District/Country;Start Year;End Year;Marker;Marker_Classification;Present;Tested;Prevalence (%);PubMedID;Year Published;Title;Authors;;;;;;
Africa;Angola;Bambi Angola;-14.339789;15.4009;Multiple sites;2019;2019;WT;Sensitive;54;54;100;33168604;2021;Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019;Pedro Rafael Dimbu. Roberta Horth. Ana Luísa M Cândido. Carolina Miguel Ferreira. Felismina Caquece. Luzala Elisabeth Armando Garcia. Kialanda André. Garcia Pembele. Domingos Jandondo. Belmira José Bondo. Benjamin Nieto Andrade. Sarah Labuda. Gabriel Ponce de León. Julia Kelley. Dhruviben Patel. Samaly S Svigel. Eldin Talundzic. Naomi Lucchi. Joana F M Morais. Filomeno Fortes. José Franco Martins. Mateusz M Pluciński.;https://pubmed.ncbi.nlm.nih.gov/33168604/;;;;;
Africa;Angola;Benguela Province;-12.590516;13.4165;Benguela;2015;2015;WT;Sensitive;137;137;100;28153004;2017;Efficacy of artemether-lumefantrine. artesunate-amodiaquine. and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola. 2015;Mateusz M Plucinski. Pedro Rafael Dimbu. Aleixo Panzo Macaia. Carolina Miguel Ferreira. Claudete Samutondo. Joltim Quivinja. Marília Afonso. Richard Kiniffo. Eliane Mbounga. Julia S Kelley. Dhruviben S Patel. Yun He. Eldin Talundzic. Denise O Garrett. Eric S Halsey. Venkatachalam Udhayakumar. Pascal Ringwald. Filomeno Fortes.;https://www.ncbi.nlm.nih.gov/pubmed/28153004;;;;;
Africa;Angola;Benguela Province;-12.590516;13.4165;Benguela;2015;2015;WT;Sensitive;185;185;100;28153004;2017;Efficacy of artemether-lumefantrine. artesunate-amodiaquine. and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola. 2015;Mateusz M Plucinski. Pedro Rafael Dimbu. Aleixo Panzo Macaia. Carolina Miguel Ferreira. Claudete Samutondo. Joltim Quivinja. Marília Afonso. Richard Kiniffo. Eliane Mbounga. Julia S Kelley. Dhruviben S Patel. Yun He. Eldin Talundzic. Denise O Garrett. Eric S Halsey. Venkatachalam Udhayakumar. Pascal Ringwald. Filomeno Fortes.;https://www.ncbi.nlm.nih.gov/pubmed/28153004;;;;;
Africa;Angola;Cabinda;-5.56;12.19;Cabinda;2018;2018;WT;Sensitive;50;50;100;33827587;2021;Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola;Emily R Ebel. Fátima Reis. Dmitri A Petrov . Sandra Beleza;https://pubmed.ncbi.nlm.nih.gov/33827587/;;;;;
Africa;Angola;Cuando Cubanga;-14.43525451;18.88938947;Cuando Cubanga;2023;2023;P441L;WHO-Candidate;2;72;2.78;NA;2024;MIM Conference. Kawela M et al Preliminary Regional Results from GenE8;;;;;;;
Africa;Angola;Cuando Cubanga;-14.43525451;18.88938947;Cuando Cubanga;2023;2023;P574L;WHO-Validated;1;72;1.39;NA;2024;MIM Conference. Kawela M et al Preliminary Regional Results from GenE8;;;;;;;
Africa;Angola;Cuando Cubanga;-14.43525451;18.88938947;Cuando Cubanga;2023;2023;WT;Sensitive;69;72;95.83;NA;2024;MIM Conference. Kawela M et al Preliminary Regional Results from GenE8;;;;;;;
Africa;Angola;Huambo;-12.5;15.66667;Huambo;2017;2017;A578S;Widespread other;2;78;2.5;27332904;2016;A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms;Didier Ménard. Nimol Khim. Johann Beghain. Ayola A Adegnika et al.;https://doi.org/10.3390/pathogens11050554;;;;;
Africa;Angola;Huambo;-12.5;15.66667;Huambo;2017;2017;WT;Sensitive;76;78;97.4;27332904;2016;A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms;Didier Ménard. Nimol Khim. Johann Beghain. Ayola A Adegnika et al.;https://doi.org/10.3390/pathogens11050555;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2012;2015;M579I;Other NS;1;102;1;28797235;2017;Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province. China from Africa;;https://pubmed.ncbi.nlm.nih.gov/33549122/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2012;2015;WT;Sensitive;101;102;99;28797235;2017;Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province. China from Africa;;https://pubmed.ncbi.nlm.nih.gov/28797235/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2012;2016;Q613E;Other NS;1;139;0.7;29436339;2018;Surveillance of Antimalarial Resistance Molecular Markers in Imported Plasmodium falciparum Malaria Cases in Anhui. China. 2012-2016;;https://pubmed.ncbi.nlm.nih.gov/29436339/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2012;2016;WT;Sensitive;138;139;99.3;29436339;2018;Surveillance of Antimalarial Resistance Molecular Markers in Imported Plasmodium falciparum Malaria Cases in Anhui. China. 2012-2016;;https://pubmed.ncbi.nlm.nih.gov/32677899/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2012;2016;WT;Sensitive;4;4;100;32677899;2020;Polymorphisms of pfcrt. pfmdr1. and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province. China;;https://pubmed.ncbi.nlm.nih.gov/31358591/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2012;2015;A569T;Other NS;1;466;0.2;33549122;2021;Molecular surveillance of pfcrt. pfmdr1 and pfk13-propeller mutations in Plasmodium falciparum isolates imported from Africa to China;;https://pubmed.ncbi.nlm.nih.gov/31358591/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2012;2015;WT;Sensitive;465;466;99.8;33549122;2021;Molecular surveillance of pfcrt. pfmdr1 and pfk13-propeller mutations in Plasmodium falciparum isolates imported from Africa to China;;https://pubmed.ncbi.nlm.nih.gov/31619243/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2013;2017;WT;Sensitive;1;38;2.6;31358591;2019;Molecular Surveillance of Drug Resistance of Plasmodium falciparum Isolates Imported from Angola in Henan Province. China;;https://pubmed.ncbi.nlm.nih.gov/31358591/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2014;2017;WT;Sensitive;1;23;4.3;31358591;2019;Molecular Surveillance of Drug Resistance of Plasmodium falciparum Isolates Imported from Angola in Henan Province. China;;https://pubmed.ncbi.nlm.nih.gov/31358591/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2014;2017;WT;Sensitive;24;24;100;31619243;2019;K13-propeller gene polymorphisms of Plasmodium falciparum and the therapeutic effect of artesunate among migrant workers returning to Guangxi. China (2014-2017);;https://pubmed.ncbi.nlm.nih.gov/32019571/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2015;2017;WT;Sensitive;1;28;3.6;31358591;2019;Molecular Surveillance of Drug Resistance of Plasmodium falciparum Isolates Imported from Angola in Henan Province. China;;https://pubmed.ncbi.nlm.nih.gov/29615039/;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2016;2017;WT;Sensitive;1;40;2.5;31358591;2019;Molecular Surveillance of Drug Resistance of Plasmodium falciparum Isolates Imported from Angola in Henan Province. China;;;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2016;2018;WT;Sensitive;1;32;3.1;32019571;2020;Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province. China between 2016 and 2018;;https://pubmed.ncbi.nlm.nih.gov/31358591/;;;;;
Africa;Angola;Kimbango Angola;-14.339789;15.4009;Multiple sites;2017;2017;WT;Sensitive;;38;;29615039;2018;Efficacy and safety of artemether-lumefantrine. artesunate-amodiaquine. and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola. 2017;;;;;;;
Africa;Angola;Kimbango Angola;-10.970819;17.44416;Cases imported from Angola to China;2017;2017;WT;Sensitive;18;18;100;31358591;2019;Molecular Surveillance of Drug Resistance of Plasmodium falciparum Isolates Imported from Angola in Henan Province. China;;;;;;;
Africa;Angola;Luanda;-8.83833;13.2344;Luanda Angola;2014;2014;R539T;WHO-Validated;1;23;4.35;28797235;2017;Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province. China from Africa.;Yang C. Zhang H. Zhou R. Qian D. Liu Y. Zhao Y. Li S. Xu B;;;;;;
Africa;Angola;Luanda;-8.83833;13.2344;Luanda Angola;2014;2014;WT;Sensitive;22;23;95.65;28797235;2017;Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province. China from Africa.;Yang C. Zhang H. Zhou R. Qian D. Liu Y. Zhao Y. Li S. Xu B;;;;;;
Africa;Angola;Lunda Sul;-9.661217;20.39046;Saurimo;2015;2015;A578S;Widespread other;1;200;0.5;28153004;2017;Efficacy of artemether-lumefantrine. artesunate-amodiaquine. and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola. 2015;Mateusz M Plucinski. Pedro Rafael Dimbu. Aleixo Panzo Macaia. Carolina Miguel Ferreira. Claudete Samutondo. Joltim Quivinja. Marília Afonso. Richard Kiniffo. Eliane Mbounga. Julia S Kelley. Dhruviben S Patel. Yun He. Eldin Talundzic. Denise O Garrett. Eric S Halsey. Venkatachalam Udhayakumar. Pascal Ringwald. Filomeno Fortes.;;;;;;
Africa;Angola;Lunda Sul;-9.661217;20.39046;Saurimo;2015;2015;WT;Sensitive;203;203;100;28153004;2017;Efficacy of artemether-lumefantrine. artesunate-amodiaquine. and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola. 2015;Mateusz M Plucinski. Pedro Rafael Dimbu. Aleixo Panzo Macaia. Carolina Miguel Ferreira. Claudete Samutondo. Joltim Quivinja. Marília Afonso. Richard Kiniffo. Eliane Mbounga. Julia S Kelley. Dhruviben S Patel. Yun He. Eldin Talundzic. Denise O Garrett. Eric S Halsey. Venkatachalam Udhayakumar. Pascal Ringwald. Filomeno Fortes.;;;;;;
Africa;Angola;Zaire;-6.269421;14.23378;M'Banza-Kongo;2015;2015;A578S;Widespread other;2;79;2.4;28153004;2017;Efficacy of artemether-lumefantrine. artesunate-amodiaquine. and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola. 2015;Mateusz M Plucinski. Pedro Rafael Dimbu. Aleixo Panzo Macaia. Carolina Miguel Ferreira. Claudete Samutondo. Joltim Quivinja. Marília Afonso. Richard Kiniffo. Eliane Mbounga. Julia S Kelley. Dhruviben S Patel. Yun He. Eldin Talundzic. Denise O Garrett. Eric S Halsey. Venkatachalam Udhayakumar. Pascal Ringwald. Filomeno Fortes.;;;;;;
Africa;Angola;Zaire;-6.269421;14.23378;M'Banza-Kongo;2015;2015;WT;Sensitive;99;99;100;28153004;2017;Efficacy of artemether-lumefantrine. artesunate-amodiaquine. and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola. 2015;Mateusz M Plucinski. Pedro Rafael Dimbu. Aleixo Panzo Macaia. Carolina Miguel Ferreira. Claudete Samutondo. Joltim Quivinja. Marília Afonso. Richard Kiniffo. Eliane Mbounga. Julia S Kelley. Dhruviben S Patel. Yun He. Eldin Talundzic. Denise O Garrett. Eric S Halsey. Venkatachalam Udhayakumar. Pascal Ringwald. Filomeno Fortes.;https://www.ncbi.nlm.nih.gov/pubmed/28153004;;;;;
Africa;Botswana;Central Botswana;-21.5832;26.0414;Central Botswana;2012;2016;WT;Sensitive;70;70;100;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283485/;2018;Molecular surveillance of Plasmodium falciparum drug resistance markers in clinical samples from Botswana.;Tawe L. Menegon M. Ramatlho P. Muthoga CW. Mutukwa N. Vurayai M. et al. The American Journal of Tropical Medicine and Hygiene. 2018_99(6):1499.;https://www.ncbi.nlm.nih.gov/pubmed/28153004;;;;;
Africa;Botswana;Ghanzi;-21.6961;21.6482;Ghanzi;2012;2016;WT;Sensitive;4;4;100;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283485/;2018;Molecular surveillance of Plasmodium falciparum drug resistance markers in clinical samples from Botswana.;Tawe L. Menegon M. Ramatlho P. Muthoga CW. Mutukwa N. Vurayai M. et al. The American Journal of Tropical Medicine and Hygiene. 2018_99(6):1499.;https://www.ncbi.nlm.nih.gov/pubmed/28153004;;;;;
Africa;Botswana;Kgalagadi;-24.755;21.8569;Kgalagadi;2012;2016;WT;Sensitive;3;3;100;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283485/;2018;Molecular surveillance of Plasmodium falciparum drug resistance markers in clinical samples from Botswana.;Tawe L. Menegon M. Ramatlho P. Muthoga CW. Mutukwa N. Vurayai M. et al. The American Journal of Tropical Medicine and Hygiene. 2018_99(6):1499.;https://www.ncbi.nlm.nih.gov/pubmed/28153004;;;;;
Africa;Botswana;Kgatleng;-24.197;26.2305;Kgatleng;2012;2016;WT;Sensitive;1;1;100;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283485/;2018;Molecular surveillance of Plasmodium falciparum drug resistance markers in clinical samples from Botswana.;Tawe L. Menegon M. Ramatlho P. Muthoga CW. Mutukwa N. Vurayai M. et al. The American Journal of Tropical Medicine and Hygiene. 2018_99(6):1499.;;;;;;
Africa;Botswana;Ngamiland;-19.9071;23.0012;Ngamiland;2012;2016;WT;Sensitive;94;94;100;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283485/;2018;Molecular surveillance of Plasmodium falciparum drug resistance markers in clinical samples from Botswana.;Tawe L. Menegon M. Ramatlho P. Muthoga CW. Mutukwa N. Vurayai M. et al. The American Journal of Tropical Medicine and Hygiene. 2018_99(6):1499.;;;;;;
Africa;Botswana;North East Botswana;-20.9031;27.4556;North East Botswana;2012;2016;WT;Sensitive;1;1;100;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283485/;2018;Molecular surveillance of Plasmodium falciparum drug resistance markers in clinical samples from Botswana.;Tawe L. Menegon M. Ramatlho P. Muthoga CW. Mutukwa N. Vurayai M. et al. The American Journal of Tropical Medicine and Hygiene. 2018_99(6):1499.;;;;;;
Africa;Botswana;South-East Botswana;-24.963;25.7812;South-East Botswana;2012;2016;WT;Sensitive;12;12;100;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283485/;2018;Molecular surveillance of Plasmodium falciparum drug resistance markers in clinical samples from Botswana.;Tawe L. Menegon M. Ramatlho P. Muthoga CW. Mutukwa N. Vurayai M. et al. The American Journal of Tropical Medicine and Hygiene. 2018_99(6):1499.;;;;;;
Africa;Comoros;Ngazidja;-11.717216;43.24731;Moroni;2017;2017;G453S;Other NS;1;63;1.6;Unpublished, WHO Threats Map;2024;Unpublished, WHO Threats Map;Programme National de Lutte Contre le Paludisme;;;;;;
Africa;Comoros;Ngazidja;-11.803499;43.2736;Hambou et de Badjine Est;2017;2017;WT;Sensitive;12;12;100;Unpublished, WHO Threats Map;2024;Unpublished, WHO Threats Map;Programme National de Lutte Contre le Paludisme;;;;;;
Africa;Comoros;Ngazidja;-11.717216;43.24731;Moroni;2017;2017;WT;Sensitive;59;60;98.4;Unpublished, WHO Threats Map;2024;Unpublished, WHO Threats Map;Programme National de Lutte Contre le Paludisme;;;;;;
Africa;Comoros;Oichili Yamboini;-11.583333;43.33333;Grande Comore;2017;2017;WT;Sensitive;16;16;100;Unpublished, WHO Threats Map;2024;Unpublished, WHO Threats Map;Programme National de Lutte Contre le Paludisme;;;;;;
Africa;DRC;Kinshasa;-4.33167;15.3139;KinshasaDemocratic Republic of the Congo;2012;2014;R561H;WHO-Validated;1;1230;0.08;27332904;2016;A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.;MÃ©nard D. Khim N. Beghain J. Adegnika AA. Shafiul-Alam M. Amodu O. Rahim-Awab G. Barnadas C. Berry A. Boum Y. Bustos MD. Cao J. Chen JH. Collet L. Cui L. Thakur GD. Dieye A. DjallÃ© D. Dorkenoo MA. Eboumbou-Moukoko CE. Espino FE. Fandeur T. Ferreira-da-Cruz MF. Fola AA. Fuehrer HP. Hassan AM. Herrera S. Hongvanthong B. HouzÃ© S. Ibrahim ML. Jahirul-Karim M. Jiang L. Kano S. Ali-Khan W. Khanthavong M. Kremsner PG. Lacerda M. Leang R. Leelawong M. Li M. Lin K. Mazarati JB. MÃ©nard S. Morlais I. Muhindo-Mavoko H. Musset L. Na-Bangchang K. Nambozi M. NiarÃ© K. Noedl H. OuÃ©draogo JB. Pillai DR. Pradines B. Quang-Phuc B. Ramharter M. Randrianarivelojosia M. Sattabongkot J. Sheikh-Omar A. SiluÃ© KD. Sirima SB. Sutherland C. Syafruddin D. Tahar R. Tang LH. TourÃ© OA. Tshibangu-wa-Tshibangu P. Vigan-Womas I. Warsame M. Wini L. Zakeri S. Kim S. Eam R. Berne L. Khean C. Chy S. Ken M. Loch K. Canier L. Duru V. Legrand E. Barale JC. Stokes B. Straimer J. Witkowski B. Fidock DA. Rogier C. Ringwald P. Ariey F. Mercereau-Puijalon O.;;;;;;
Africa;DRC;Kinshasa;-4.33167;15.3139;KinshasaDemocratic Republic of the Congo;2012;2014;WT;Sensitive;1229;1230;99.98;27332904;2016;A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.;MÃ©nard D. Khim N. Beghain J. Adegnika AA. Shafiul-Alam M. Amodu O. Rahim-Awab G. Barnadas C. Berry A. Boum Y. Bustos MD. Cao J. Chen JH. Collet L. Cui L. Thakur GD. Dieye A. DjallÃ© D. Dorkenoo MA. Eboumbou-Moukoko CE. Espino FE. Fandeur T. Ferreira-da-Cruz MF. Fola AA. Fuehrer HP. Hassan AM. Herrera S. Hongvanthong B. HouzÃ© S. Ibrahim ML. Jahirul-Karim M. Jiang L. Kano S. Ali-Khan W. Khanthavong M. Kremsner PG. Lacerda M. Leang R. Leelawong M. Li M. Lin K. Mazarati JB. MÃ©nard S. Morlais I. Muhindo-Mavoko H. Musset L. Na-Bangchang K. Nambozi M. NiarÃ© K. Noedl H. OuÃ©draogo JB. Pillai DR. Pradines B. Quang-Phuc B. Ramharter M. Randrianarivelojosia M. Sattabongkot J. Sheikh-Omar A. SiluÃ© KD. Sirima SB. Sutherland C. Syafruddin D. Tahar R. Tang LH. TourÃ© OA. Tshibangu-wa-Tshibangu P. Vigan-Womas I. Warsame M. Wini L. Zakeri S. Kim S. Eam R. Berne L. Khean C. Chy S. Ken M. Loch K. Canier L. Duru V. Legrand E. Barale JC. Stokes B. Straimer J. Witkowski B. Fidock DA. Rogier C. Ringwald P. Ariey F. Mercereau-Puijalon O.;;;;;;
Africa;DRC;Kabondo;-8.906147881;25.66816516;Kabondo;2021;2021;R561H;WHO-Validated;1;100;1;38016502;2024;Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo;;;;;;;
Africa;DRC;Kabondo;-8.906147881;25.66816516;Kabondo;2021;2021;WT;Sensitive;99;100;99;38016502;2024;Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo;;;;;;;
Africa;DRC;Rushuru;-1.185494692;29.44696415;Rushuru;2020;2020;P441L;WHO-Candidate;1;100;1;38016502;2024;Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo;;;;;;;
Africa;DRC;Rushuru;-1.185494692;29.44696415;Rushuru;2020;2020;WT;Sensitive;99;100;99;38016502;2024;Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo;;;;;;;
Africa;Kenya;Kakamega;0.2829067345;34.75288625;Kakamega;2018;2022;A675V;WHO-Validated;3;126;2.38;38287365;2024;Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia.;;;;;;;
Africa;Kenya;Kakamega;0.2829067345;34.75288625;Kakamega;2018;2022;WT;Sensitive;123;126;97.62;38287365;2024;Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia.;;;;;;;
Africa;Kenya;Kisii County;-0.680580052;34.7694101;Kisii County;2021;2021;N488Y;Other NS;1;13;7.69;36894982;2024;Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment;;;;;;;
Africa;Kenya;Kisii County;-0.680580052;34.7694101;Kisii County;2021;2021;R539T;WHO-Validated;1;13;7.69;36894982;2024;Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment;;;;;;;
Africa;Kenya;Kisii County;-0.680580052;34.7694101;Kisii County;2021;2021;R561H;WHO-Validated;1;13;7.69;36894982;2024;Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment;;;;;;;
Africa;Kenya;Kisii County;-0.680580052;34.7694101;Kisii County;2021;2021;WT;Sensitive;10;13;76.92;36894982;2024;Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment;;;;;;;
Africa;Malawi;Blantyre;-15.75934696;35.01805878;Blantyre;2016;2016;WT;Sensitive;2;2;100.0% [34.24 - 100.0];29813085;;Resistance screening and trend analysis of imported falciparum malaria in NSW, Australia (2010 to 2016).;Prosser C, Meyer W, Ellis J, Lee R;;;;;;
Africa;Malawi;Lilongwe;-13.96319962;33.7120018;Lilongwe;2014;2014;WT;Sensitive;13;13;100.0% [77.19 - 100.0];27332904;;A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.;Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, Rahim-Awab G, Barnadas C, Berry A, Boum Y, Bustos MD, Cao J, Chen JH, Collet L, Cui L, Thakur GD, Dieye A, Djallé D, Dorkenoo MA, Eboumbou-Moukoko CE, Espino FE, Fandeur T, Ferreira-da-Cruz MF, Fola AA, Fuehrer HP, Hassan AM, Herrera S, Hongvanthong B, Houzé S, Ibrahim ML, Jahirul-Karim M, Jiang L, Kano S, Ali-Khan W, Khanthavong M, Kremsner PG, Lacerda M, Leang R, Leelawong M, Li M, Lin K, Mazarati JB, Ménard S, Morlais I, Muhindo-Mavoko H, Musset L, Na-Bangchang K, Nambozi M, Niaré K, Noedl H, Ouédraogo JB, Pillai DR, Pradines B, Quang-Phuc B, Ramharter M, Randrianarivelojosia M, Sattabongkot J, Sheikh-Omar A, Silué KD, Sirima SB, Sutherland C, Syafruddin D, Tahar R, Tang LH, Touré OA, Tshibangu-wa-Tshibangu P, Vigan-Womas I, Warsame M, Wini L, Zakeri S, Kim S, Eam R, Berne L, Khean C, Chy S, Ken M, Loch K, Canier L, Duru V, Legrand E, Barale JC, Stokes B, Straimer J, Witkowski B, Fidock DA, Rogier C, Ringwald P, Ariey F, Mercereau-Puijalon O,;;;;;;
Africa;Mozambique;Maputo Mozambique;-25.9667;32.5833;Mozambique;2017;2017;R622I;WHO-Validated;1;7;14.29;32019571;2020;Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province. China between 2016 and 2018.;Wang X. Ruan W. Zhou S. Huang F. Lu Q. Feng X. Yan H;;;;;;
Africa;Mozambique;Niassa;-12.1858868;36.02963328;Niassa;2021;2021;A578P;Other NS;1;100;1;37208708;2023;Anti-malarial resistance in Mozambique: Absence of Plasmodium falciparum Kelch 13 (K13) propeller domain polymorphisms associated with resistance to artemisinins;;;;;;;
Africa;Mozambique;Niassa;-12.1858868;36.02963328;Niassa;2021;2021;WT;Sensitive;99;100;99;37208708;2023;Anti-malarial resistance in Mozambique: Absence of Plasmodium falciparum Kelch 13 (K13) propeller domain polymorphisms associated with resistance to artemisinins;;;;;;;
Africa;Mozambique;Pooled 9 sites;-25.9692;32.5732;Pooled 9 sites;2021;2022;WT;Sensitive;1154;1154;100;Unpublished, WHO Threats Map;2024;MIM Genomic surveillance of Plasmodium falciparum Drug Resistance Markers and Genetic Diversity in Mozambique;;;;;;;
Africa;Namibia;Zambezi region;-17.8193;23.9536;Zambezi 95%. Kavango 5%;2023;2023;A675V;WHO-Validated;3;151;1.99;Unpublished, WHO Threats Map;2024;"MIM Conference. Kawela M et al Preliminary Regional Results from GenE8; 9th Annual Southern Africa Malaria Research Conference Conference 2024; Eloff, L, Genomic surveillance reveals artemisinin partial resistance markers in Northern Namibia in 2023 from 9th Annual Southern Africa Malaria Research Conference Conference 2024";Lydia Eloff, Andrés Aranda-Díaz, Isobel Routledge, Mukosha Chisenga, Brighton Mangena, John Chimumbwa, Chadwick Sikaala, Petrina Uusiku, Stark Katokele, Jennifer Smith, Jaishree Raman, Davis R. Mumbengegwi;;;;;;
Africa;Namibia;Zambezi region;-17.8193;23.9536;Zambezi 95%. Kavango 5%;2023;2023;P441L;WHO-Candidate;58;151;38.41;Unpublished, WHO Threats Map;2024;"MIM Conference. Kawela M et al Preliminary Regional Results from GenE8; 9th Annual Southern Africa Malaria Research Conference Conference 2024; Eloff, L, Genomic surveillance reveals artemisinin partial resistance markers in Northern Namibia in 2023 from 9th Annual Southern Africa Malaria Research Conference Conference 2024";Lydia Eloff, Andrés Aranda-Díaz, Isobel Routledge, Mukosha Chisenga, Brighton Mangena, John Chimumbwa, Chadwick Sikaala, Petrina Uusiku, Stark Katokele, Jennifer Smith, Jaishree Raman, Davis R. Mumbengegwi;;;;;;
Africa;Namibia;Zambezi region;-17.8193;23.9536;Zambezi 95%. Kavango 5%;2023;2023;P574L;WHO-Validated;3;151;1.99;Unpublished, WHO Threats Map;2024;"MIM Conference. Kawela M et al Preliminary Regional Results from GenE8; 9th Annual Southern Africa Malaria Research Conference Conference 2024; Eloff, L, Genomic surveillance reveals artemisinin partial resistance markers in Northern Namibia in 2023 from 9th Annual Southern Africa Malaria Research Conference Conference 2024";Lydia Eloff, Andrés Aranda-Díaz, Isobel Routledge, Mukosha Chisenga, Brighton Mangena, John Chimumbwa, Chadwick Sikaala, Petrina Uusiku, Stark Katokele, Jennifer Smith, Jaishree Raman, Davis R. Mumbengegwi;;;;;;
Africa;Namibia;Zambezi region;-17.8193;23.9536;Zambezi 95%. Kavango 5%;2023;2023;R515K;Other NS;2;151;1.32;Unpublished, WHO Threats Map;2024;"MIM Conference. Kawela M et al Preliminary Regional Results from GenE8; 9th Annual Southern Africa Malaria Research Conference Conference 2024; Eloff, L, Genomic surveillance reveals artemisinin partial resistance markers in Northern Namibia in 2023 from 9th Annual Southern Africa Malaria Research Conference Conference 2024";Lydia Eloff, Andrés Aranda-Díaz, Isobel Routledge, Mukosha Chisenga, Brighton Mangena, John Chimumbwa, Chadwick Sikaala, Petrina Uusiku, Stark Katokele, Jennifer Smith, Jaishree Raman, Davis R. Mumbengegwi;;;;;;
Africa;Namibia;Zambezi region;-17.8193;23.9536;Zambezi 95%. Kavango 5%;2023;2023;WT;Sensitive;86;151;56.95;Unpublished, WHO Threats Map;2024;"MIM Conference. Kawela M et al Preliminary Regional Results from GenE8; 9th Annual Southern Africa Malaria Research Conference Conference 2024; Eloff, L, Genomic surveillance reveals artemisinin partial resistance markers in Northern Namibia in 2023 from 9th Annual Southern Africa Malaria Research Conference Conference 2024";;;;;;;
Africa;Rwanda;Bugarama;-2.69748;29.0111;BugaramaRwanda;2018;2018;C469F;WHO-Candidate;1;85;1.18;33864801;2021;Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label. single-arm. multicentre. therapeutic efficacy study.;Uwimana A. Umulisa N. Venkatesan M. Svigel SS. Zhou Z. Munyaneza T. Habimana RM. Rucogoza A. Moriarty LF. Sandford R. Piercefield E. Goldman I. Ezema B. Talundzic E. Pacheco MA. Escalante AA. Ngamije D. Mangala JN. Kabera M. Munguti K. Murindahabi M. Brieger W. Musanabaganwa C. Mutesa L. Udhayakumar V. Mbituyumuremyi A. Halsey ES. Lucchi NW;;;;;;
Africa;Rwanda;Bugarama;-2.69748;29.0111;BugaramaRwanda;2018;2018;R561H;WHO-Validated;1;85;1.18;33864801;2021;Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label. single-arm. multicentre. therapeutic efficacy study.;Uwimana A. Umulisa N. Venkatesan M. Svigel SS. Zhou Z. Munyaneza T. Habimana RM. Rucogoza A. Moriarty LF. Sandford R. Piercefield E. Goldman I. Ezema B. Talundzic E. Pacheco MA. Escalante AA. Ngamije D. Mangala JN. Kabera M. Munguti K. Murindahabi M. Brieger W. Musanabaganwa C. Mutesa L. Udhayakumar V. Mbituyumuremyi A. Halsey ES. Lucchi NW;;;;;;
Africa;Rwanda;Bugarama;-2.69748;29.0111;BugaramaRwanda;2018;2018;WT;Sensitive;84;85;98.82;33864801;2021;Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label. single-arm. multicentre. therapeutic efficacy study.;Uwimana A. Umulisa N. Venkatesan M. Svigel SS. Zhou Z. Munyaneza T. Habimana RM. Rucogoza A. Moriarty LF. Sandford R. Piercefield E. Goldman I. Ezema B. Talundzic E. Pacheco MA. Escalante AA. Ngamije D. Mangala JN. Kabera M. Munguti K. Murindahabi M. Brieger W. Musanabaganwa C. Mutesa L. Udhayakumar V. Mbituyumuremyi A. Halsey ES. Lucchi NW;;;;;;
Africa;Rwanda;Huye;-2.613412874;29.8290959;Huye;2023;2023;R561H;WHO-Validated;9;99;9;38092677;2024;Escalating Plasmodium falciparum K13 marker prevalence indicative of artemisinin resistance in southern Rwanda;;;;;;;
Africa;Rwanda;Huye;-2.613412874;29.8290959;Huye;2023;2023;WT;Sensitive;90;99;90.91;38092677;2024;Escalating Plasmodium falciparum K13 marker prevalence indicative of artemisinin resistance in southern Rwanda;;;;;;;
Africa;Rwanda;Huye District;-2.56041;29.7181;Huye DistrictRwanda;2019;2019;A675V;WHO-Validated;1;66;1.52;33350925;2021;Increase in Kelch 13 Polymorphisms in Plasmodium falciparum. Southern Rwanda.;Bergmann C. van Loon W. Habarugira F. Tacoli C. JÃ¤ger JC. Savelsberg D. Nshimiyimana F. Rwamugema E. Mbarushimana D. Ndoli J. Sendegeya A. Bayingana C. Mockenhaupt FP;;;;;;
Africa;Rwanda;Huye District;-2.56041;29.7181;Huye DistrictRwanda;2019;2019;C469F;WHO-Candidate;1;66;1.52;33350925;2021;Increase in Kelch 13 Polymorphisms in Plasmodium falciparum. Southern Rwanda.;Bergmann C. van Loon W. Habarugira F. Tacoli C. JÃ¤ger JC. Savelsberg D. Nshimiyimana F. Rwamugema E. Mbarushimana D. Ndoli J. Sendegeya A. Bayingana C. Mockenhaupt FP;;;;;;
Africa;Rwanda;Huye District;-2.56041;29.7181;Huye DistrictRwanda;2019;2019;R561H;WHO-Validated;3;66;4.55;33350925;2021;Increase in Kelch 13 Polymorphisms in Plasmodium falciparum. Southern Rwanda.;Bergmann C. van Loon W. Habarugira F. Tacoli C. JÃ¤ger JC. Savelsberg D. Nshimiyimana F. Rwamugema E. Mbarushimana D. Ndoli J. Sendegeya A. Bayingana C. Mockenhaupt FP;;;;;;
Africa;Rwanda;Huye District;-2.56041;29.7181;Huye DistrictRwanda;2019;2019;WT;Sensitive;63;66;95.45;33350925;2021;Increase in Kelch 13 Polymorphisms in Plasmodium falciparum. Southern Rwanda.;Bergmann C. van Loon W. Habarugira F. Tacoli C. JÃ¤ger JC. Savelsberg D. Nshimiyimana F. Rwamugema E. Mbarushimana D. Ndoli J. Sendegeya A. Bayingana C. Mockenhaupt FP;;;;;;
Africa;Rwanda;Kamonyi Rwanda;-1.94028;29.8739;Rwanda;2017;2017;R561H;WHO-Validated;1;1;100;32019571;2020;Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province. China between 2016 and 2018.;Wang X. Ruan W. Zhou S. Huang F. Lu Q. Feng X. Yan H;;;;;;
Africa;Rwanda;Kigali;-1.95463;30.0345;KigaliRwanda;2018;2018;C469F;WHO-Candidate;3;73;4.11;34216470;2022;High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine.;Straimer J. Gandhi P. Renner KC. Schmitt EK;;;;;;
Africa;Rwanda;Kigali;-1.95463;30.0345;KigaliRwanda;2018;2018;P574L;WHO-Validated;1;73;1.37;34216470;2022;High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine.;Straimer J. Gandhi P. Renner KC. Schmitt EK;;;;;;
Africa;Rwanda;Kigali;-1.95463;30.0345;KigaliRwanda;2018;2018;R561H;WHO-Validated;16;73;21.92;34216470;2022;High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine.;Straimer J. Gandhi P. Renner KC. Schmitt EK;;;;;;
Africa;Rwanda;Kigali;-1.940915992;30.05537328;Kigali;2018;2019;R561H;WHO-Validated;15;66;22;38092677;2024;Escalating Plasmodium falciparum K13 marker prevalence indicative of artemisinin resistance in southern Rwanda;;;;;;;
Africa;Rwanda;Kigali;-1.940915992;30.05537328;Kigali;2018;2019;WT;Sensitive;51;66;77.27;38092677;2024;Escalating Plasmodium falciparum K13 marker prevalence indicative of artemisinin resistance in southern Rwanda;;;;;;;
Africa;Rwanda;Masaka;-1.99169;30.2121;MasakaRwanda;2018;2018;P441L;WHO-Candidate;1;52;1.92;33864801;2021;Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label. single-arm. multicentre. therapeutic efficacy study.;Uwimana A. Umulisa N. Venkatesan M. Svigel SS. Zhou Z. Munyaneza T. Habimana RM. Rucogoza A. Moriarty LF. Sandford R. Piercefield E. Goldman I. Ezema B. Talundzic E. Pacheco MA. Escalante AA. Ngamije D. Mangala JN. Kabera M. Munguti K. Murindahabi M. Brieger W. Musanabaganwa C. Mutesa L. Udhayakumar V. Mbituyumuremyi A. Halsey ES. Lucchi NW;;;;;;
Africa;Rwanda;Masaka;-1.99169;30.2121;MasakaRwanda;2018;2018;R561H;WHO-Validated;9;52;17.31;33864801;2021;Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label. single-arm. multicentre. therapeutic efficacy study.;Uwimana A. Umulisa N. Venkatesan M. Svigel SS. Zhou Z. Munyaneza T. Habimana RM. Rucogoza A. Moriarty LF. Sandford R. Piercefield E. Goldman I. Ezema B. Talundzic E. Pacheco MA. Escalante AA. Ngamije D. Mangala JN. Kabera M. Munguti K. Murindahabi M. Brieger W. Musanabaganwa C. Mutesa L. Udhayakumar V. Mbituyumuremyi A. Halsey ES. Lucchi NW;;;;;;
Africa;Rwanda;Masaka Ruhuha;-1.99169;30.2121;Masaka RuhuhaRwanda;2014;2014;C469Y;WHO-Validated;1;382;0.26;32747827;2020;Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda.;Uwimana A. Legrand E. Stokes BH. Ndikumana JM. Warsame M. Umulisa N. Ngamije D. Munyaneza T. Mazarati JB. Munguti K. Campagne P. Criscuolo A. Ariey F. Murindahabi M. Ringwald P. Fidock DA. Mbituyumuremyi A. Menard D;;;;;;
Africa;Rwanda;Masaka Ruhuha;-1.99169;30.2121;Masaka RuhuhaRwanda;2014;2014;P574L;WHO-Validated;1;382;0.26;32747827;2020;Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda.;Uwimana A. Legrand E. Stokes BH. Ndikumana JM. Warsame M. Umulisa N. Ngamije D. Munyaneza T. Mazarati JB. Munguti K. Campagne P. Criscuolo A. Ariey F. Murindahabi M. Ringwald P. Fidock DA. Mbituyumuremyi A. Menard D;;;;;;
Africa;Rwanda;Masaka Ruhuha;-1.99169;30.2121;Masaka RuhuhaRwanda;2014;2014;R561H;WHO-Validated;12;382;3.14;32747827;2020;Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda.;Uwimana A. Legrand E. Stokes BH. Ndikumana JM. Warsame M. Umulisa N. Ngamije D. Munyaneza T. Mazarati JB. Munguti K. Campagne P. Criscuolo A. Ariey F. Murindahabi M. Ringwald P. Fidock DA. Mbituyumuremyi A. Menard D;;;;;;
Africa;Rwanda;Masaka Ruhuha;-1.99169;30.2121;Masaka RuhuhaRwanda;2015;2015;R561H;WHO-Validated;7;93;7.53;32747827;2020;Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda.;Uwimana A. Legrand E. Stokes BH. Ndikumana JM. Warsame M. Umulisa N. Ngamije D. Munyaneza T. Mazarati JB. Munguti K. Campagne P. Criscuolo A. Ariey F. Murindahabi M. Ringwald P. Fidock DA. Mbituyumuremyi A. Menard D;;;;;;
Africa;Rwanda;Rukara;-1.80002;30.5042;RukaraRwanda;2018;2018;C469F;WHO-Candidate;2;82;2.44;33864801;2021;Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label. single-arm. multicentre. therapeutic efficacy study.;Uwimana A. Umulisa N. Venkatesan M. Svigel SS. Zhou Z. Munyaneza T. Habimana RM. Rucogoza A. Moriarty LF. Sandford R. Piercefield E. Goldman I. Ezema B. Talundzic E. Pacheco MA. Escalante AA. Ngamije D. Mangala JN. Kabera M. Munguti K. Murindahabi M. Brieger W. Musanabaganwa C. Mutesa L. Udhayakumar V. Mbituyumuremyi A. Halsey ES. Lucchi NW;;;;;;
Africa;Rwanda;Rukara;-1.80002;30.5042;RukaraRwanda;2018;2018;R561H;WHO-Validated;16;82;19.51;33864801;2021;Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label. single-arm. multicentre. therapeutic efficacy study.;Uwimana A. Umulisa N. Venkatesan M. Svigel SS. Zhou Z. Munyaneza T. Habimana RM. Rucogoza A. Moriarty LF. Sandford R. Piercefield E. Goldman I. Ezema B. Talundzic E. Pacheco MA. Escalante AA. Ngamije D. Mangala JN. Kabera M. Munguti K. Murindahabi M. Brieger W. Musanabaganwa C. Mutesa L. Udhayakumar V. Mbituyumuremyi A. Halsey ES. Lucchi NW;;;;;;
Africa;Rwanda;Rukara;-1.80002;30.5042;RukaraRwanda;2018;2018;WT;Sensitive;64;82;78.04;33864801;2021;Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label. single-arm. multicentre. therapeutic efficacy study.;Uwimana A. Umulisa N. Venkatesan M. Svigel SS. Zhou Z. Munyaneza T. Habimana RM. Rucogoza A. Moriarty LF. Sandford R. Piercefield E. Goldman I. Ezema B. Talundzic E. Pacheco MA. Escalante AA. Ngamije D. Mangala JN. Kabera M. Munguti K. Murindahabi M. Brieger W. Musanabaganwa C. Mutesa L. Udhayakumar V. Mbituyumuremyi A. Halsey ES. Lucchi NW;;;;;;
Africa;Rwanda;Rukara;-1.800839943;30.50331855;Rukara;2021;2021;A675V;WHO-Validated;6;94;6.4;38755607;2024;Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda;;;;;;;
Africa;Rwanda;Rukara;-1.800839943;30.50331855;Rukara;2021;2021;P574L;WHO-Validated;2;84;2.4;38755607;2024;Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda;;;;;;;
Africa;Rwanda;Rukara;-1.800839943;30.50331855;Rukara;2021;2021;R561H;WHO-Validated;20;85;23.5;38755607;2024;Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda;;;;;;;
Africa;Rwanda;Rukara;-1.800839943;30.50331855;Rukara;2021;2021;WT;Sensitive;66;94;70.21;38755607;2024;Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda;;;;;;;
Africa;South Africa;KwaZulu Natal Mpumalanga;-25.6699;31.8119;KwaZulu Natal Mpumalanga;2022;2022;Other NS;Other NS;6;652;0.92;https://www.nicd.ac.za/wp-content/uploads/2022/08/310822-NICD-Monthly-Communique-Aug-NW5.pdf;2022;"Malaria update: Increase in frequency of Kelch 13 mutations found
in malaria parasites from Mpumalanga Province. an early warning of
the possible emergence of artemisinin-resistant malaria";Raman J;;;;;;
Africa;South Africa;KwaZulu Natal Mpumalanga Limpopo;-25.6699;31.8119;KwaZulu Natal Mpumalanga Limpopo;2021;2021;Q613E;Other NS;1;501;0.2;https://www.nicd.ac.za/wp-content/uploads/2021/08/NICD-Monthly-Communique%CC%81-August.pdf;2021;"Malaria treatment: first detection of the Plasmodium
falciparum kelch 13 Q613E mutation in South Africa";Raman J;;;;;;https://pubmed.ncbi.nlm.nih.gov/33002448/
Africa;South Africa;KwaZulu Natal Mpumalanga Limpopo;-25.6699;31.8119;KwaZulu Natal Mpumalanga Limpopo;2021;2021;WT;Sensitive;500;501;99.8;https://www.nicd.ac.za/wp-content/uploads/2021/08/NICD-Monthly-Communique%CC%81-August.pdf;2021;"Malaria treatment: first detection of the Plasmodium
falciparum kelch 13 Q613E mutation in South Africa";Raman J;;;;;;
Africa;South Africa;KwaZulu Natal Mpumalanga Limpopo;-25.4467;31.8119;KwaZulu Natal Mpumalanga Limpopo;2022;2022;WT;Sensitive;646;652;99.08;https://www.nicd.ac.za/wp-content/uploads/2022/08/310822-NICD-Monthly-Communique-Aug-NW5.pdf;2022;"Malaria update: Increase in frequency of Kelch 13 mutations found
in malaria parasites from Mpumalanga Province. an early warning of
the possible emergence of artemisinin-resistant malaria";Raman J;;;;;;
Africa;South Africa;KwaZulu Natal Mpumalanga Limpopo;-25.4467;31.8119;KwaZulu Natal Mpumalanga Limpopo;2023;2023;Other NS;Other NS;6;669;0.9;Unpublished;Unpublished;Unpublished;Raman J;;;;;;
Africa;South Africa;KwaZulu Natal Mpumalanga Limpopo;-25.6699;31.8119;KwaZulu Natal Mpumalanga Limpopo;2023;2023;WT;Sensitive;663;669;99.1;Unpublished;Unpublished;Unpublished;Raman J;;;;;;
Africa;South Africa;Mpumalanga;-25.6699;31.8119;Mpumalanga;2016;2018;WT;Sensitive;164;164;100;31234865;2019;Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label. randomized controlled trial.;Raman J. Allen E. Workman L. et al.;;;;;;
Africa;South Africa;Mpumalanga;-25.6699;31.8119;Mpumalanga;2018;2018;WT;Sensitive;532;532;100;31438951;2019;Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province. South Africa (2001–2018).;Raman. J.. Kagoro. F.M.. Mabuza. A. et al.;;;;;;
Africa;South Africa;Mpumulanga;-25.6699;31.8119;Mpumulanga;2016;2018;WT;Sensitive;164;164;100;31234865;2019;Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label. randomized controlled trial.;Raman J. Allen E. Workman L. et al.;;;;;;
Africa;South Africa;Mpumulanga;-25.6699;31.8119;Mpumulanga;2018;2018;WT;Sensitive;532;532;100;31438951;2019;Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province. South Africa (2001–2018).;Raman. J.. Kagoro. F.M.. Mabuza. A. et al.;;;;;;
Africa;South Africa;Mpumulanga;-25.6699;31.8119;Mpumulanga;2022;2023;A578S;Widespread other;5;990;0.5;Unpublished;2023;Unpublished;Raman J;;;;;;
Africa;South Africa;Mpumulanga;-25.6699;31.8119;Mpumulanga;2022;2023;E455G;Other NS;1;990;0.1;Unpublished;2023;Unpublished;Raman J;;;;;;
Africa;South Africa;Mpumulanga;-25.6699;31.8119;Mpumulanga;2022;2023;E556K;Other NS;1;990;0.1;Unpublished;2023;Unpublished;Raman J;;;;;;
Africa;South Africa;Mpumulanga;-25.6699;31.8119;Mpumulanga;2022;2023;N537S;Other NS;2;990;0.2;Unpublished;2023;Unpublished;Raman J;;;;;;
Africa;South Africa;Mpumulanga;-25.6699;31.8119;Mpumulanga;2022;2023;S521L;Other NS;1;990;0.1;Unpublished;2023;Unpublished;Raman J;;;;;;
Africa;South Africa;Mpumulanga;-25.67;31.812;Mpumulanga;2022;2023;WT;Sensitive;980;990;99;Unpublished;2023;Unpublished;Raman J;;;;;;
Africa;South Africa;Nkomazi;-25.4467;31.9447;Mpumalanga;2018;2020;WT;Sensitive;2385;2385;100;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Nkomazi Mpumalanga;-25.6699;31.8119;Nkomazi Mpumalanga;2018;2020;WT;Sensitive;2385;2385;100;35768869;2022;Making data map-worthy-enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study.;Kagoro FM. Allen E. Mabuza A. et al.;;;;;;
Africa;South Africa;Nkomazi Mpumulanga;-25.6699;31.8119;Nkomazi Mpumulanga;2018;2020;WT;Sensitive;2385;2385;100;35768869;2022;Making data map-worthy-enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study.;Kagoro FM. Allen E. Mabuza A. et al.;;;;;;
Africa;South Africa;Pooled MPU;-25.4467;31.9447;Mpumalanga;2016;2018;WT;Sensitive;164;164;100;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Pooled MPU;-25.4467;31.9447;Mpumalanga;2018;2018;WT;Sensitive;532;532;100;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Pooled MPU KZN;-25.4467;31.9447;Pooled MPU KZN;2021;2021;613E;Other NS;1;501;0.2;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Pooled MPU KZN;-25.4467;31.9447;Pooled MPU KZN;2021;2021;WT;Sensitive;500;501;99.8;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Pooled MPU KZN;-25.4467;31.9447;Pooled MPU KZN;2022;2023;WT;Sensitive;1237;1247;99.2;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Pooled MPU KZN;-25.6699;31.9447;Pooled MPU KZN;2023;2024;WT;Sensitive;604;604;100;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Pooled MPU KZN LP;-25.6699;31.9447;Pooled MPU KZN;2022;2023;E455G;Other NS;1;1247;0.08;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Pooled MPU KZN LP;-25.4467;31.9447;Pooled MPU KZN;2022;2023;521L;Other NS;1;1247;0.08;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Pooled MPU KZN LP;-25.4467;31.9447;Pooled MPU KZN;2022;2023;537S;Other NS;2;1247;0.16;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Pooled MPU KZN LP;-25.4467;31.9447;Pooled MPU KZN;2022;2023;556K;Other NS;1;1247;0.08;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;South Africa;Pooled MPU KZN LP;-25.6699;31.9447;Pooled MPU KZN;2022;2023;A578S;Widespread other;5;1247;0.4;Unpublished;Unpublished;Unpublished;Unpublished;;;;;;
Africa;Tanzania;Bagamoyo;-6.433333;38.900002​;Bagamoyo;2017;2018;WT;Sensitive;35;35;100;32576258;2020;Parasite clearance. cure rate. post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district. Tanzania: a randomized controlled trial;Mhamilawa LE. Ngasala B. Morris U. Kitabi EN. Barnes R. Soe AP. Mmbando BP. Björkman A. Mårtensson A.;;;;;;
Africa;Tanzania;Buhigwe;-4.49724;29.8913;BuhigweTanzania;2017;2017;R561H;WHO-Validated;1;70;1.43;33107096;2021;Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes.;Moser KA. Madebe RA. Aydemir O. Chiduo MG. Mandara CI. Rumisha SF. Chaky F. Denton M. Marsh PW. Verity R. Watson OJ. Ngasala B. Mkude S. Molteni F. Njau R. Warsame M. Mandike R. Kabanywanyi AM. Mahende MK. Kamugisha E. Ahmed M. Kavishe RA. Greer G. Kitojo CA. Reaves EJ. Mlunde L. Bishanga D. Mohamed A. Juliano JJ. Ishengoma DS. Bailey JA;;;;;;
Africa;Tanzania;Buhigwe;-4.49724;29.8913;BuhigweTanzania;2017;2017;WT;Sensitive;69;70;98.57;33107096;2021;Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes.;Moser KA. Madebe RA. Aydemir O. Chiduo MG. Mandara CI. Rumisha SF. Chaky F. Denton M. Marsh PW. Verity R. Watson OJ. Ngasala B. Mkude S. Molteni F. Njau R. Warsame M. Mandike R. Kabanywanyi AM. Mahende MK. Kamugisha E. Ahmed M. Kavishe RA. Greer G. Kitojo CA. Reaves EJ. Mlunde L. Bishanga D. Mohamed A. Juliano JJ. Ishengoma DS. Bailey JA;;;;;;
Africa;Tanzania;Chato;-2.63896;31.7685;ChatoTanzania;2017;2017;R561H;WHO-Validated;1;82;1.22;33107096;2021;Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes.;Moser KA. Madebe RA. Aydemir O. Chiduo MG. Mandara CI. Rumisha SF. Chaky F. Denton M. Marsh PW. Verity R. Watson OJ. Ngasala B. Mkude S. Molteni F. Njau R. Warsame M. Mandike R. Kabanywanyi AM. Mahende MK. Kamugisha E. Ahmed M. Kavishe RA. Greer G. Kitojo CA. Reaves EJ. Mlunde L. Bishanga D. Mohamed A. Juliano JJ. Ishengoma DS. Bailey JA;;;;;;
Africa;Tanzania;Chato;-2.63896;31.7685;ChatoTanzania;2017;2017;WT;Sensitive;81;82;98.78;33107096;2021;Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes.;Moser KA. Madebe RA. Aydemir O. Chiduo MG. Mandara CI. Rumisha SF. Chaky F. Denton M. Marsh PW. Verity R. Watson OJ. Ngasala B. Mkude S. Molteni F. Njau R. Warsame M. Mandike R. Kabanywanyi AM. Mahende MK. Kamugisha E. Ahmed M. Kavishe RA. Greer G. Kitojo CA. Reaves EJ. Mlunde L. Bishanga D. Mohamed A. Juliano JJ. Ishengoma DS. Bailey JA;;;;;;
Africa;Tanzania;Coastal Kibiti;-7.72411;38.9359;CoastalKibitiTanzania;2019;2019;R561H;WHO-Validated;1;422;0.24;32103124;2020;Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania.;Bwire GM. Ngasala B. Mikomangwa WP. Kilonzi M. Kamuhabwa AAR;;;;;;
Africa;Tanzania;Coastal Kibiti;-7.72411;38.9359;CoastalKibitiTanzania;2019;2019;WT;Sensitive;421;422;99.76;32103124;2020;Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania.;Bwire GM. Ngasala B. Mikomangwa WP. Kilonzi M. Kamuhabwa AAR;;;;;;
Africa;Tanzania;Dar es Salaam;-6.8165;39.2894;Dar es Salaam;2021;2021;WT;Sensitive;161;161;100;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Dodoma;-6.163;35.7516;Dodoma;2021;2021;WT;Sensitive;188;188;100;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Kagera;-1.3001115;31.2626366;Kagera;2021;2021;A675V;WHO-Validated;1;680;0.15;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Kagera;-1.3001115;31.2626366;Kagera;2021;2021;R561H;WHO-Validated;50;649;7.7;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Kagera;-1.3001115;31.2626366;Kagera;2021;2021;WT;Sensitive;658;709;92.8;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Karagwe district;-1.734470235;31.06276582;Karagwe district;2022;2022;R561H;WHO-Validated;39;173;22.54;39159633;2024;Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.;;;;;;;
Africa;Tanzania;Karagwe district;-1.734470235;31.06276582;Karagwe district;2022;2022;WT;Sensitive;134;173;77.46;39159633;2024;Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.;;;;;;;
Africa;Tanzania;Kigoma;-4.8824;29.6615;Kigoma;2021;2021;WT;Sensitive;100;100;100;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Kilimanjaro;-3.0674;37.3556;Kilimanjaro;2021;2021;WT;Sensitive;204;204;100;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Manyara;-4.315;36.9541;Manyara;2021;2021;R561H;WHO-Validated;1;179;0.56;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Manyara;-4.315;36.9541;Manyara;2021;2021;WT;Sensitive;235;236;99.58;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Mara;-1.75;34;Mara;2021;2021;WT;Sensitive;585;585;100;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Mtwara;-10.3112;40.176;Mtwara;2021;2021;WT;Sensitive;170;170;100;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Njombe;-9.3732;34.8005;Njombe;2021;2021;R561H;WHO-Validated;1;279;0.36;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Njombe;-9.3732;34.8005;Njombe;2021;2021;R622I;WHO-Validated;1;345;0.29;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Njombe;-9.3732;34.8005;Njombe;2021;2021;WT;Sensitive;343;345;99.42;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Ruvuma;-10.6879;36.2631;Ruvuma;2021;2021;WT;Sensitive;68;68;100;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Songwe;-8.5238;32.5373;Songwe;2021;2021;WT;Sensitive;377;377;100;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Tabora;-5.0425;32.8269;Tabora;2021;2021;A675V;WHO-Validated;1;464;0.22;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Tabora;-5.0425;32.8269;Tabora;2021;2021;R561H;WHO-Validated;2;438;0.46;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Tabora;-5.0425;32.8269;Tabora;2021;2021;WT;Sensitive;495;498;99.4;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Tanzania;Tanga;-5.0889;39.1023;Tanga;2021;2021;WT;Sensitive;56;56;100;37986920;2023;Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.;Juliano JJ. Giesbrecht DJ. Simkin A. Fola AA. Lyimo BM. Pereus D. Bakari C. Madebe RA. Seth MD. Mandara CI. Popkin-Hall ZR. Moshi R. Mbwambo RB. Niaré K. MacInnis B. Francis F. Mbwambo D. Garimo I. Chacky F. Aaron S. Lusasi A. Molteni F. Njau RJA. Lazaro S. Mohamed A. Bailey JA. Ishengoma DS.;;;;;;
Africa;Uganda;Acholi;3.05719144;32.93083689;Acholi;2021;2023;A675V;WHO-Validated;4;59;6.78;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Uganda;Acholi;3.05719144;32.93083689;Acholi;2021;2023;C469Y;WHO-Validated;8;59;13.6;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Uganda;Acholi;3.05719144;32.93083689;Acholi;2021;2023;WT;Sensitive;52;59;13.6;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Uganda;Acholi sub-region;3.05719144;32.93083689;Acholi sub-region;2016;2017;C469Y;WHO-Validated;17;50;34;39136465;2024;A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda;;;;;;;
Africa;Uganda;Acholi sub-region;3.05719144;32.93083689;Acholi sub-region;2016;2017;WT;Sensitive;33;50;66;39136465;2024;A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda;;;;;;;
Africa;Uganda;Adjumani;3.381441;31.7831;Adjumani;2022;2022;A569S;Other NS;1;80;1.25;38712186;2024;Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district. Uganda.;Angwe MK. Mwebaza N. Nsobya SL. Vudriko P. Dralabu S. Omali D. Tumwebaze MA. Ocan M.;;;;;;
Africa;Uganda;Adjumani;3.381441;31.7831;Adjumani;2022;2022;A578S;Widespread other;1;80;1.25;38712186;2024;Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district. Uganda.;Angwe MK. Mwebaza N. Nsobya SL. Vudriko P. Dralabu S. Omali D. Tumwebaze MA. Ocan M.;;;;;;
Africa;Uganda;Adjumani;3.381441;31.7831;Adjumani;2022;2022;A675V;WHO-Validated;2;80;2.5;38712186;2024;Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district. Uganda.;Angwe MK. Mwebaza N. Nsobya SL. Vudriko P. Dralabu S. Omali D. Tumwebaze MA. Ocan M.;;;;;;
Africa;Uganda;Adjumani;3.381441;31.7831;Adjumani;2022;2022;C469Y;WHO-Validated;10;80;12.5;38712186;2024;Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district. Uganda.;Angwe MK. Mwebaza N. Nsobya SL. Vudriko P. Dralabu S. Omali D. Tumwebaze MA. Ocan M.;medRxiv;;;;;
Africa;Uganda;Adjumani;3.381441;31.7831;Adjumani;2022;2022;F491S;Other NS;1;80;1.25;38712186;2024;Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district. Uganda.;Angwe MK. Mwebaza N. Nsobya SL. Vudriko P. Dralabu S. Omali D. Tumwebaze MA. Ocan M.;medRxiv;;;;;
Africa;Uganda;Adjumani;3.381441;31.7831;Adjumani;2022;2022;WT;Sensitive;65;80;81.25;38712186;2024;Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district. Uganda.;Angwe MK. Mwebaza N. Nsobya SL. Vudriko P. Dralabu S. Omali D. Tumwebaze MA. Ocan M.;medRxiv;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2016;2016;WT;Sensitive;30;30;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;medRxiv;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2017;2017;C469Y;WHO-Candidate;1;42;2.4;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;medRxiv;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2017;2017;A675V;WHO-Validated;1;42;2.4;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;medRxiv;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2017;2017;A675V;WHO-Validated;2;44;4.55;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2017;2017;WT;Sensitive;42;44;95.45;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2018;2018;A675V;WHO-Validated;1;50;3;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2018;2018;C469Y;WHO-Validated;1;50;3.1;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2018;2018;WT;Sensitive;48;50;96;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2018;2018;A675V;WHO-Validated;1;35;2.85;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2018;2018;C469Y;WHO-Validated;1;31;3.23;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2018;2018;P441L;WHO-Candidate;1;31;3.23;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2018;2018;WT;Sensitive;32;35;91.42;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2019;2019;A675V;WHO-Validated;5;45;31.2;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2019;2019;C469Y;WHO-Validated;3;45;15.8;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2019;2019;A675V;WHO-Validated;8;46;17.39;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2019;2019;C469Y;WHO-Validated;10;47;21.27;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2019;2019;WT;Sensitive;21;47;78.63;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2020;2020;A675V;WHO-Validated;13;79;16.45;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2020;2020;C469Y;WHO-Validated;33;79;41.77;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2021;2021;A675V;WHO-Validated;7;52;13.46;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2021;2021;C469Y;WHO-Validated;8;50;16;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2021;2021;WT;Sensitive;18;79;22.78;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2022;2022;A675V;WHO-Validated;9;68;13.23;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2022;2022;C469Y;WHO-Validated;19;67;28.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2022;2022;WT;Sensitive;40;67;59.7;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2022;2023;A569S;Other NS;1;252;0.4;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2022;2023;A578S;Widespread other;0;252;0;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2022;2023;A675V;WHO-Validated;14;237;5.907172996;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2022;2023;C469Y;WHO-Validated;55;234;21.8;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2022;2023;C580Y;WHO-Validated;0;252;0;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Agago;2.98472;33.3306;Agago;2022;2023;WT;Sensitive;182;252;72.22;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2016;2016;WT;Sensitive;28;28;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2017;2017;WT;Sensitive;48;48;100;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2017;2017;C469Y;WHO-Validated;2;49;4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Conrad MD. Asua V. Garg S. Giesbrecht D. Niaré K. Smith S. Namuganga JF. Katairo T. Legac J. Crudale RM. Tumwebaze PK;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2018;2018;WT;Sensitive;50;50;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2018;2018;WT;Sensitive;28;28;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2019;2019;WT;Sensitive;35;35;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2019;2019;WT;Sensitive;28;28;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2020;2020;WT;Sensitive;85;85;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2021;2021;A675V;WHO-Validated;4;8;50;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2021;2021;WT;Sensitive;4;8;50;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Amolatar;1.63333;32.8333;Amolatar;2022;2022;WT;Sensitive;13;13;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2016;2016;WT;Sensitive;33;33;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2017;2017;A675V;WHO-Validated;1;43;2.3;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2018;2018;WT;Sensitive;44;44;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2018;2018;WT;Sensitive;30;30;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2019;2019;A675V;WHO-Validated;1;49;4;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2019;2019;WT;Sensitive;48;49;96;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2019;2019;A675V;WHO-Validated;1;29;3.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2019;2019;WT;Sensitive;28;29;96.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2020;2020;WT;Sensitive;81;81;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2021;2021;A675V;WHO-Validated;1;68;1.5;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2021;2021;C469Y;WHO-Validated;2;68;2.9;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2021;2021;WT;Sensitive;66;68;97.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2022;2022;A675V;WHO-Validated;2;78;2.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2022;2022;C469Y;WHO-Validated;6;76;7.9;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2022;2022;P441L;WHO-Candidate;1;76;1.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2022;2022;WT;Sensitive;67;76;88.15;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2022;2023;A569S;Other NS;0;236;0;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2022;2023;A578S;Widespread other;3;234;1.282051282;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2022;2023;A675V;WHO-Validated;13;223;5.829596413;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2022;2023;C469Y;WHO-Validated;5;232;2.155172414;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2022;2023;C580Y;WHO-Validated;1;236;0.4237288136;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Arua;3.03;30.91;Arua;2022;2023;WT;Sensitive;214;236;90.67;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Busia;0.4664;34.0886;Busia;2022;2023;A569S;Other NS;0;265;0;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Busia;0.4664;34.0886;Busia;2022;2023;A578S;Widespread other;4;261;1.53256705;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Busia;0.4664;34.0886;Busia;2022;2023;A675V;WHO-Validated;6;259;2.316602317;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Busia;0.4664;34.0886;Busia;2022;2023;C469Y;WHO-Validated;1;264;0.3787878788;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Busia;0.4664;34.0886;Busia;2022;2023;C580Y;WHO-Validated;0;265;0;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Busia;0.4664;34.0886;Busia;2022;2023;WT;Sensitive;254;265;95.85;Unavailable;2024;NMCP, Victor Asua;EFFICACY AND SAFETY OF ARTEMETHER-LUMEFANTRINE, PYRONARIDINE-ARTESUNATE, ARTESUNATE-AMODIAQUINE AND DIHYDROARTEMISININ-PIPERAQUINE FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CHILDREN IN UGANDA;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2018;2018;WT;Sensitive;50;50;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2018;2018;C469F;WHO-Candidate;1;42;2.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2018;2018;WT;Sensitive;41;42;97.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2019;2019;WT;Sensitive;49;49;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2019;2019;P441L;WHO-Candidate;1;79;1.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2019;2019;WT;Sensitive;83;83;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2020;2020;A675V;WHO-Validated;6;92;6.5;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2020;2020;C469Y;WHO-Validated;8;92;8.7;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2020;2020;WT;Sensitive;78;92;84.78;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2021;2021;WT;Sensitive;82;82;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2022;2022;A675V;WHO-Validated;14;63;22.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2022;2022;A675V;WHO-Validated;49;63;78.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2022;2022;WT;Sensitive;60;60;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Hoima;1.42975;31.3556;Hoima;2022;2022;WT;Sensitive;53;53;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2016;2016;WT;Sensitive;29;29;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2017;2017;WT;Sensitive;48;48;100;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2018;2018;C469Y;WHO-Validated;0;43;0;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2018;2018;WT;Sensitive;43;43;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2018;2018;R561H;WHO-Validated;1;38;2.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2018;2018;WT;Sensitive;37;38;97.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2019;2019;WT;Sensitive;50;50;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2019;2019;WT;Sensitive;91;91;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2020;2020;WT;Sensitive;96;96;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2021;2021;WT;Sensitive;95;95;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2021;2021;WT;Sensitive;74;74;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2022;2022;A675V;WHO-Validated;1;99;1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Jinja;0.424444;33.2042;Jinja;2022;2022;WT;Sensitive;99;99;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2018;2018;A675V;WHO-Validated;4;50;10;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2018;2018;C469Y;WHO-Validated;2;50;5.9;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2018;2018;A675V;WHO-Validated;3;34;8.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2018;2018;C469Y;WHO-Validated;2;30;6.7;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2018;2018;WT;Sensitive;39;50;78;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2019;2019;A675V;WHO-Validated;9;47;40.9;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2019;2019;C469Y;WHO-Validated;1;47;4.3;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2019;2019;A675V;WHO-Validated;10;46;21.7;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2019;2019;WT;Sensitive;26;46;56.5;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2020;2020;A675V;WHO-Validated;14;75;18.7;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2020;2020;C469Y;WHO-Validated;13;75;17.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2020;2020;WT;Sensitive;13;75;17.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2021;2021;A675V;WHO-Validated;10;59;16.9;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2021;2021;C469F;WHO-Candidate;3;57;5.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2021;2021;C469Y;WHO-Validated;7;57;12.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2022;2022;A675V;WHO-Validated;4;68;5.9;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2022;2022;C469Y;WHO-Validated;10;64;15.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kaabong;3.51472;34.1321;Kaabong;2022;2022;WT;Sensitive;54;64;84;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kabale;-1.24196;29.9856;Kabale;2018;2018;WT;Sensitive;47;47;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Kabale;-1.24196;29.9856;Kabale;2019;2019;A675V;WHO-Validated;1;15;7.7;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Kabale;-1.24196;29.9856;Kabale;2019;2019;WT;Sensitive;14;15;82.3;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2016;2016;WT;Sensitive;37;37;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;3.51472;34.1321;Kanungu;2017;2017;WT;Sensitive;48;48;100;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;;;;;;
Africa;Uganda;Kanungu;3.51472;34.1321;Kanungu;2018;2018;WT;Sensitive;50;50;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2018;2018;C469F;WHO-Candidate;1;36;2.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2018;2018;C469F;WHO-Candidate;35;36;97.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;3.51472;34.1321;Kanungu;2019;2019;WT;Sensitive;49;49;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2019;2019;WT;Sensitive;64;64;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2020;2020;C469F;WHO-Candidate;4;91;4.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2020;2020;P441L;WHO-Candidate;2;91;2.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2020;2020;WT;Sensitive;89;91;97.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2021;2021;C469F;WHO-Candidate;2;46;4.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2021;2021;P441L;WHO-Candidate;3;50;6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2021;2021;WT;Sensitive;45;50;90;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2022;2022;A675V;WHO-Validated;2;64;3.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2022;2022;P441L;WHO-Candidate;15;65;23.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2022;2022;R561H;WHO-Validated;1;51;2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kanungu;-0.819525;29.7426;Kanungu;2022;2022;WT;Sensitive;18;65;27.69;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kapchorwa;1.3973;34.4489;Kapchorwa;2016;2016;WT;Sensitive;16;16;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kapchorwa;1.3973;34.4489;Kapchorwa;2019;2019;WT;Sensitive;41;41;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Kapchorwa;1.3973;34.4489;Kapchorwa;2019;2019;WT;Sensitive;16;16;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kapchorwa;1.3973;34.4489;Kapchorwa;2021;2021;A675V;WHO-Validated;3;71;4.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kapchorwa;1.3973;34.4489;Kapchorwa;2021;2021;C469Y;WHO-Validated;1;77;1.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kapchorwa;1.3973;34.4489;Kapchorwa;2021;2021;WT;Sensitive;77;77;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kapchorwa;1.3973;34.4489;Kapchorwa;2022;2022;A675V;WHO-Validated;9;30;30;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kapchorwa;1.3973;34.4489;Kapchorwa;2022;2022;C469Y;WHO-Validated;2;27;7.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kapchorwa;1.3973;34.4489;Kapchorwa;2022;2022;WT;Sensitive;16;27;59.25;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Karamoja;3.320540691;33.40258836;Karamoja;2021;2023;A675V;WHO-Validated;5;60;8.3;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Uganda;Karamoja;3.320540691;33.40258836;Karamoja;2021;2023;C469Y;WHO-Validated;14;60;23.3;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Uganda;Karamoja;3.320540691;33.40258836;Karamoja;2021;2023;WT;Sensitive;45;60;75;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2018;2018;WT;Sensitive;26;26;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2019;2019;WT;Sensitive;47;47;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2019;2019;P441L;WHO-Candidate;2;61;3.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2019;2019;WT;Sensitive;59;61;96.7;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2020;2020;P441L;WHO-Candidate;2;89;2.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2020;2020;WT;Sensitive;92;92;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2021;2021;P441L;WHO-Candidate;11;76;14.5;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2021;2021;WT;Sensitive;78;78;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2022;2022;A675V;WHO-Validated;3;92;3.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2022;2022;C469Y;WHO-Validated;8;91;8.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2022;2022;P441L;WHO-Candidate;14;91;15.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kasese;0.172391;30.0867;Kasese;2022;2022;WT;Sensitive;66;91;72.52;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2018;2018;A675V;WHO-Validated;2;50;4.5;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2018;2018;C469Y;WHO-Validated;2;50;4.8;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2018;2018;WT;Sensitive;46;50;92;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2018;2018;A675V;WHO-Validated;1;45;2.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2018;2018;C469Y;WHO-Validated;2;40;5;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2018;2018;WT;Sensitive;42;45;93.33;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2019;2019;A675V;WHO-Validated;2;47;6.7;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2019;2019;C469Y;WHO-Validated;2;47;6.2;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2019;2019;C469Y;WHO-Validated;2;50;6.2;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2019;2019;WT;Sensitive;44;50;88;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2019;2019;A675V;WHO-Validated;6;57;10.5;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2019;2019;WT;Sensitive;48;61;78.69;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2019;2019;C469Y;WHO-Validated;3;61;4.9;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2020;2020;A675V;WHO-Validated;6;88;6.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2020;2020;C469Y;WHO-Validated;12;87;13.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2020;2020;P441L;WHO-Candidate;2;87;2.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2020;2020;WT;Sensitive;67;87;77;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2021;2021;A675V;WHO-Validated;9;58;15.5;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2021;2021;C469Y;WHO-Validated;7;58;12.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2021;2021;WT;Sensitive;42;58;72.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2022;2022;A675V;WHO-Validated;14;75;18.7;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2022;2022;C469Y;WHO-Validated;18;78;23.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Katakwi;1.91601;33.9602;Katakwi;2022;2022;WT;Sensitive;46;78;58.97;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2018;2018;WT;Sensitive;50;50;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2018;2018;WT;Sensitive;34;34;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2019;2019;WT;Sensitive;49;49;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2019;2019;WT;Sensitive;5;5;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2020;2020;A675V;WHO-Validated;5;64;7.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2020;2020;C469Y;WHO-Validated;2;55;3.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2020;2020;WT;Sensitive;53;55;96.36;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2021;2021;A675V;WHO-Validated;5;44;11.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2021;2021;C469Y;WHO-Validated;1;46;2.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2021;2021;WT;Sensitive;45;46;97.82;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2022;2022;A675V;WHO-Validated;6;47;12.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2022;2022;C469Y;WHO-Validated;1;48;2.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Koboko;3.4168;30.9589;Koboko;2022;2022;WT;Sensitive;41;48;91.11;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2016;2016;C469Y;WHO-Validated;1;23;4.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2016;2016;WT;Sensitive;22;23;95.7;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2017;2017;A675V;WHO-Validated;1;47;2.1;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2017;2017;C469Y;WHO-Validated;1;47;2.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2017;2017;WT;Sensitive;46;47;95.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2018;2018;A675V;WHO-Validated;1;34;2.9;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.34893783;32.73223446;Kole;2018;2020;A675V;WHO-Validated;1;53;1.9;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Kole;2.34893783;32.73223446;Kole;2018;2020;V581A;Other NS;1;53;1.9;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Kole;2.34893783;32.73223446;Kole;2018;2020;V650I;Other NS;1;53;1.9;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Kole;2.34893783;32.73223446;Kole;2018;2020;WT;Sensitive;50;53;94.3;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2019;2019;C469Y;WHO-Validated;5;46;17.9;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2019;2019;A675V;WHO-Validated;2;60;3.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2019;2019;C469Y;WHO-Validated;3;56;5.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2019;2019;WT;Sensitive;51;56;91;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2020;2020;A675V;WHO-Validated;10;86;11.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2020;2020;C469Y;WHO-Validated;12;85;14.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2020;2020;WT;Sensitive;63;85;74.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2021;2021;A675V;WHO-Validated;2;58;3.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2022;2022;A675V;WHO-Validated;6;78;7.7;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2022;2022;C469Y;WHO-Validated;9;74;12.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kole;2.42861;32.8011;Kole;2022;2022;WT;Sensitive;57;74;77;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Kwania;1.958695623;32.74903888;Kwania;2018;2020;A578S;Widespread other;2;56;3.6;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Kwania;1.958695623;32.74903888;Kwania;2018;2020;WT;Sensitive;53;56;94.6;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Kwania;1.958695623;32.74903888;Kwania;2018;2020;Y546H;Other NS;1;33;3;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Kwania;1.958695623;32.74903888;Kwania;2018;2020;WT;Sensitive;32;33;97;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Kyangwali;1.220884313;30.82119169;Kyangwali;2022;2022;A613S;Other NS;0;78;0;38874098;2024;Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda;;;;;;;
Africa;Uganda;Kyangwali;1.220884313;30.82119169;Kyangwali;2022;2022;A675V;WHO-Validated;4;91;4.4;38874098;2024;Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda;;;;;;;
Africa;Uganda;Kyangwali;1.220884313;30.82119169;Kyangwali;2022;2022;C469Y;WHO-Validated;1;90;1.1;38874098;2024;Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda;;;;;;;
Africa;Uganda;Kyangwali;1.220884313;30.82119169;Kyangwali;2022;2022;WT;Sensitive;89;90;98.9;38874098;2024;Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda;;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2016;2016;A675V;WHO-Validated;2;37;5.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2016;2016;C469Y;WHO-Validated;3;33;9.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2016;2016;WT;Sensitive;28;33;84.84;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2017;2017;C469Y;WHO-Candidate;1;43;2.3;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2017;2017;A675V;WHO-Validated;5;44;11.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2017;2017;WT;Sensitive;38;44;86.36;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2018;2018;A675V;WHO-Validated;1;50;2.9;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2018;2018;C469Y;WHO-Validated;7;47;20.6;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2018;2018;A675V;WHO-Validated;1;36;2.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2018;2018;WT;Sensitive;21;36;59.33;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2018;2018;C469Y;WHO-Validated;8;34;23.5;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2019;2019;A675V;WHO-Validated;5;40;22.7;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2019;2019;C469Y;WHO-Validated;6;40;23.1;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2019;2019;C469Y;WHO-Validated;6;40;23.1;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2019;2019;A675V;WHO-Validated;6;49;12.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2019;2019;C469Y;WHO-Validated;5;50;10;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2019;2019;WT;Sensitive;5;50;10;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2020;2020;A675V;WHO-Validated;16;84;19;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2020;2020;C469Y;WHO-Validated;28;84;33.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2020;2020;WT;Sensitive;40;84;47.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2021;2021;A675V;WHO-Validated;12;53;22.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2021;2021;C469Y;WHO-Validated;16;51;31.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2021;2021;WT;Sensitive;23;51;45.09;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2022;2022;A675V;WHO-Validated;8;53;15.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2022;2022;C469Y;WHO-Validated;11;53;20.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lamwo;3.53333;32.8;Lamwo;2022;2022;WT;Sensitive;34;53;64.15;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Lango;2.291715504;33.07230336;Lango;2021;2023;A675V;WHO-Validated;5;60;8.3;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Uganda;Lango;2.291715504;33.07230336;Lango;2021;2023;C469Y;WHO-Validated;9;60;23.3;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Uganda;Lango;2.291715504;33.07230336;Lango;2021;2023;WT;Sensitive;46;60;57.5;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2016;2016;WT;Sensitive;28;28;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2017;2017;C469Y;WHO-Candidate;1;45;2.2;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2017;2017;WT;Sensitive;44;45;97.8;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2018;2018;WT;Sensitive;50;50;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2018;2018;C469F;WHO-Candidate;4;38;10.5;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2018;2018;WT;Sensitive;34;38;89.9;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2019;2019;WT;Sensitive;41;41;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2019;2019;WT;Sensitive;24;24;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2020;2020;A675V;WHO-Validated;6;87;6.9;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2020;2020;C469Y;WHO-Validated;3;88;3.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2020;2020;P441L;WHO-Candidate;1;88;1.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2020;2020;WT;Sensitive;78;88;88.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2021;2021;P441L;WHO-Candidate;1;19;5.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2021;2021;WT;Sensitive;19;19;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2022;2022;A675V;WHO-Validated;6;53;11.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2022;2022;P441L;WHO-Candidate;6;52;11.5;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Mubende;0.5575;31.395;Mubende;2022;2022;WT;Sensitive;41;52;78.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Oyam;2.398130743;32.39115861;Oyam;2018;2020;G625R;Other NS;1;53;1.9;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Oyam;2.398130743;32.39115861;Oyam;2018;2020;L631F;Other NS;1;53;1.9;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Oyam;2.398130743;32.39115861;Oyam;2018;2020;WT;Sensitive;51;53;96.2;39028193;2024;Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.;;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2016;2016;C469F;WHO-Candidate;8;42;19;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2016;2016;WT;Sensitive;36;42;81;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2019;2019;A675V;WHO-Validated;1;21;4.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2019;2019;WT;Sensitive;20;21;95.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2020;2020;A675V;WHO-Validated;1;39;2.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2020;2020;C469F;WHO-Candidate;11;39;28.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2020;2020;WT;Sensitive;39;39;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2021;2021;A675V;WHO-Validated;2;82;2.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2021;2021;C469F;WHO-Candidate;29;72;40.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2021;2021;P441L;WHO-Candidate;1;83;1.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2021;2021;R561H;WHO-Validated;11;67;16.4;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2021;2021;WT;Sensitive;11;67;48.18;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2022;2022;A675V;WHO-Validated;3;59;5.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2022;2022;C469F;WHO-Candidate;23;60;38.3;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2022;2022;C469Y;WHO-Validated;1;46;2.2;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2022;2022;R561H;WHO-Validated;12;53;22.6;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Rukiga;-1.1326;30.0434;Rukiga;2022;2022;WT;Sensitive;21;60;35;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2016;2016;C469F;WHO-Candidate;1;35;2.9;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2016;2016;WT;Sensitive;34;35;97.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2017;2017;WT;Sensitive;48;48;100;30559133;2019;Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.;Asua V. Vinden J. Conrad MD. Legac J. Kigozi SP. Kamya MR. Dorsey G. Nsobya SL. Rosenthal PJ;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2017;2017;A675V;WHO-Validated;1;48;2.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2017;2017;C469F;WHO-Candidate;1;48;2.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2017;2017;WT;Sensitive;46;48;95.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2018;2018;WT;Sensitive;50;50;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2018;2018;WT;Sensitive;43;43;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2019;2019;WT;Sensitive;46;46;100;33146722;2019;Changing Prevalence of Potential Mediators of Aminoquinoline. Antifolate. and Artemisinin Resistance Across Uganda.;Asua V. Conrad MD. Aydemir O. Duvalsaint M. Legac J. Duarte E. Tumwebaze P. Chin DM. Cooper RA. Yeka A. Kamya MR. Dorsey G. Nsobya SL. Bailey J. Rosenthal PJ;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2019;2019;WT;Sensitive;73;73;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2020;2020;WT;Sensitive;5;5;100;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2021;2021;A675V;WHO-Validated;3;74;4.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2021;2021;C469Y;WHO-Validated;3;73;4.1;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2022;2022;A675V;WHO-Validated;9;57;15.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2022;2022;C469Y;WHO-Validated;5;51;9.8;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo;0.692778;34.1811;Tororo;2022;2022;WT;Sensitive;31;74;41.89;37611122;2023;Evolution of artemisinin partial resistance in Ugandan malaria parasites;Melissa D. Conrad. Victor Asua. Shreeya Garg. David Giesbrecht. Karamoko Niaré. Sawyer Smith. Jane F. Namuganga. M.H.S.. et al.. and Philip J. Rosenthal;;;;;;
Africa;Uganda;Tororo Mbale;0.692778;34.1811;Tororo MbaleUganda;2021;2021;A675V;WHO-Validated;1;39;2.56;36289202;2022;Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda.;Tumwebaze PK. Conrad MD. Okitwi M. Orena S. Byaruhanga O. Katairo T. Legac J. Garg S. Giesbrecht D. Smith SR. Ceja FG. Nsobya SL. Bailey JA. Cooper RA. Rosenthal PJ;;;;;;
Africa;Uganda;Tororo Mbale;0.692778;34.1811;Tororo MbaleUganda;2021;2021;C469Y;WHO-Validated;1;39;2.56;36289202;2022;Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda.;Tumwebaze PK. Conrad MD. Okitwi M. Orena S. Byaruhanga O. Katairo T. Legac J. Garg S. Giesbrecht D. Smith SR. Ceja FG. Nsobya SL. Bailey JA. Cooper RA. Rosenthal PJ;;;;;;
Africa;Uganda;Tororo Mbale;0.692778;34.1811;Tororo MbaleUganda;2021;2021;WT;Sensitive;37;39;94.87;36289202;2022;Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda.;Tumwebaze PK. Conrad MD. Okitwi M. Orena S. Byaruhanga O. Katairo T. Legac J. Garg S. Giesbrecht D. Smith SR. Ceja FG. Nsobya SL. Bailey JA. Cooper RA. Rosenthal PJ;;;;;;
Africa;Uganda;West Nile;3.617324963;31.82773331;West Nile;2021;2023;C469Y;WHO-Validated;1;59;1.7;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Uganda;West Nile;3.617324963;31.82773331;West Nile;2021;2023;WT;Sensitive;58;59;98.31;Preprint;2024;Emerging threat of Partial Artemisinin ResistanceMarkers in P. falciparum Parasite Populations inmultiple geographical locations in highTransmission Regions of Uganda;;;;;;;
Africa;Zambia;Lusaka;-15.4165;28.2037;LusakaZambia;2012;2014;R622I;WHO-Validated;1;298;0.34;27332904;2016;A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.;Macnard D. Khim N. Beghain J. Adegnika AA. Shafiul-Alam M. Amodu O. Rahim-Awab G. Barnadas C. Berry A. Boum Y. Bustos MD. Cao J. Chen JH. Collet L. Cui L. Thakur GD. Dieye A. DjallacD. Dorkenoo MA. Eboumbou-Moukoko CE. Espino FE. Fandeur T. Ferreira-da-Cruz MF. Fola AA. Fuehrer HP. Hassan AM. Herrera S. Hongvanthong B. HouzÃ© S. Ibrahim ML. Jahirul-Karim M. Jiang L. Kano S. Ali-Khan W. Khanthavong M. Kremsner PG. Lacerda M. Leang R. Leelawong M. Li M. Lin K. Mazarati JB. Macnard S. Morlais I. Muhindo-Mavoko H. Musset L. Na-Bangchang K. Nambozi M. Niar K. Noedl H. Oudraogo JB. Pillai DR. Pradines B. Quang-Phuc B. Ramharter M. Randrianarivelojosia M. Sattabongkot J. Sheikh-Omar A. SiluÃ© KD. Sirima SB. Sutherland C. Syafruddin D. Tahar R. Tang LH. TourÃ© OA. Tshibangu-wa-Tshibangu P. Vigan-Womas I. Warsame M. Wini L. Zakeri S. Kim S. Eam R. Berne L. Khean C. Chy S. Ken M. Loch K. Canier L. Duru V. Legrand E. Barale JC. Stokes B. Straimer J. Witkowski B. Fidock DA. Rogier C. Ringwald P. Ariey F. Mercereau-Puijalon O.;;;;;;
Africa;Zambia;Lusaka;-15.41650009;28.20369911;Lusaka;2014;2014;WT;Sensitive;7;7;100;28797235;2017;Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province, China from Africa.;Yang C, Zhang H, Zhou R, Qian D, Liu Y, Zhao Y, Li S, Xu B;;;;;;
Africa;Zambia;Lusaka;-15.41650009;28.20369911;Lusaka;2015;2015;WT;Sensitive;4;4;100;28797235;2017;Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province, China from Africa.;Yang C, Zhang H, Zhou R, Qian D, Liu Y, Zhao Y, Li S, Xu B;;;;;;
Africa;Zambia;Pooled from 4 sites;-15.4155;28.2773;Pooled from 4 sites (Western 49. NW 54. Central 91. Lusaka 53);2023;2023;P441L;WHO-Candidate;37;247;14.98;Unpublished;2024;MIM Conference. Kawela M et al Preliminary Regional Results from GenE8;;;;;;;
Africa;Zambia;Pooled from 4 sites;-15.4155;28.2773;Pooled from 4 sites (Western 49. NW 54. Central 91. Lusaka 53);2023;2023;P574L;WHO-Validated;4;247;1.62;Unpublished;2024;MIM Conference. Kawela M et al Preliminary Regional Results from GenE8;;;;;;;
Africa;Zambia;Pooled from 4 sites;-15.4155;28.2773;Pooled from 4 sites (Western 49. NW 54. Central 91. Lusaka 53);2023;2023;WT;Sensitive;206;247;83.4;Unpublished;2024;MIM Conference. Kawela M et al Preliminary Regional Results from GenE8;;;;;;;
Africa;Zambia;Southern and Western Provinces;-16.352192;25.09171;Southern and Western Provinces;2017;2017;A578S;Widespread other;1;70;1.4;Unpublished;Unpublished;Unpublished;Centre for International Health. University of Bergen. Norway_ University of Zambia;;;;;;
Africa;Zambia;Southern and Western Provinces;-16.352192;25.09171;Southern and Western Provinces;2017;2017;T478;Other NS;1;70;1.4;Unpublished;Unpublished;Unpublished;Centre for International Health. University of Bergen. Norway_ University of Zambia;;;;;;
Africa;Zambia;Southern and Western Provinces;-16.352192;25.09171;Southern and Western Provinces;2017;2017;V666;Other NS;1;70;1.4;Unpublished;Unpublished;Unpublished;Centre for International Health. University of Bergen. Norway_ University of Zambia;;;;;;
Africa;Zimbabwe;Harare;-17.81629944;30.91679955;Harare;2014;2014;WT;Sensitive;7;7;100;Unpublished;Unpublished;Unpublished;Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, Rahim-Awab G, Barnadas C, Berry A, Boum Y, Bustos MD, Cao J, Chen JH, Collet L, Cui L, Thakur GD, Dieye A, Djallé D, Dorkenoo MA, Eboumbou-Moukoko CE, Espino FE, Fandeur T, Ferreira-da-Cruz MF, Fola AA, Fuehrer HP, Hassan AM, Herrera S, Hongvanthong B, Houzé S, Ibrahim ML, Jahirul-Karim M, Jiang L, Kano S, Ali-Khan W, Khanthavong M, Kremsner PG, Lacerda M, Leang R, Leelawong M, Li M, Lin K, Mazarati JB, Ménard S, Morlais I, Muhindo-Mavoko H, Musset L, Na-Bangchang K, Nambozi M, Niaré K, Noedl H, Ouédraogo JB, Pillai DR, Pradines B, Quang-Phuc B, Ramharter M, Randrianarivelojosia M, Sattabongkot J, Sheikh-Omar A, Silué KD, Sirima SB, Sutherland C, Syafruddin D, Tahar R, Tang LH, Touré OA, Tshibangu-wa-Tshibangu P, Vigan-Womas I, Warsame M, Wini L, Zakeri S, Kim S, Eam R, Berne L, Khean C, Chy S, Ken M, Loch K, Canier L, Duru V, Legrand E, Barale JC, Stokes B, Straimer J, Witkowski B, Fidock DA, Rogier C, Ringwald P, Ariey F, Mercereau-Puijalon O,;;;;;;
Africa;DRC;Rushuru;-1.185494692;29.44696415;Rushuru;2020;2020;P441L;WHO-Candidate;1;100;1;38016502;2024;Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo;Gauthier Mesia Kahunu, Sarah Wellmann Thomsen, Louise Wellmann Thomsen, Hypolite Muhindo Mavoko, Patrick Mitashi Mulopo, Emma Filtenborg Hocke, Papy Mandoko Nkoli, Vito Baraka, Daniel T.R. Minja, Andria Mousa, Cally Roper, Destin Mbongi Moke, Dieudonné Mumba Ngoyi, Eric Mukomena Sompwe, Jean Jacques Muyembe Tanfum, Helle Hansson and Michael Alifrangis;;;;;;
Africa;DRC;Rushuru;-1.185494692;29.44696415;Rushuru;2020;2020;WT;Sensitive;99;100;99;38016502;2024;Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo;Gauthier Mesia Kahunu, Sarah Wellmann Thomsen, Louise Wellmann Thomsen, Hypolite Muhindo Mavoko, Patrick Mitashi Mulopo, Emma Filtenborg Hocke, Papy Mandoko Nkoli, Vito Baraka, Daniel T.R. Minja, Andria Mousa, Cally Roper, Destin Mbongi Moke, Dieudonné Mumba Ngoyi, Eric Mukomena Sompwe, Jean Jacques Muyembe Tanfum, Helle Hansson and Michael Alifrangis;;;;;;
Africa;DRC;Kabondo;-8.906147881;25.66816516;Kabondo;2021;2021;R561H;WHO-Validated;1;100;1;38016502;2024;Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo;Gauthier Mesia Kahunu, Sarah Wellmann Thomsen, Louise Wellmann Thomsen, Hypolite Muhindo Mavoko, Patrick Mitashi Mulopo, Emma Filtenborg Hocke, Papy Mandoko Nkoli, Vito Baraka, Daniel T.R. Minja, Andria Mousa, Cally Roper, Destin Mbongi Moke, Dieudonné Mumba Ngoyi, Eric Mukomena Sompwe, Jean Jacques Muyembe Tanfum, Helle Hansson and Michael Alifrangis;;;;;;
Africa;DRC;Kabondo;-8.906147881;25.66816516;Kabondo;2021;2021;WT;Sensitive;99;100;99;38016502;2024;Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo;Gauthier Mesia Kahunu, Sarah Wellmann Thomsen, Louise Wellmann Thomsen, Hypolite Muhindo Mavoko, Patrick Mitashi Mulopo, Emma Filtenborg Hocke, Papy Mandoko Nkoli, Vito Baraka, Daniel T.R. Minja, Andria Mousa, Cally Roper, Destin Mbongi Moke, Dieudonné Mumba Ngoyi, Eric Mukomena Sompwe, Jean Jacques Muyembe Tanfum, Helle Hansson and Michael Alifrangis;;;;;;
Africa;Madagascar;Ankazomborona;-16.1008;46.6843;Ankazomborona|Madagascar;2018;2018;WT;Sensitive;31;31;100;34732201;Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.;Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.;Dentinger CM, Rakotomanga TA, Rakotondrandriana A, Rakotoarisoa A, Rason MA, Moriarty LF, Steinhardt LC, Kapesa L, Razafindrakoto J, Svigel SS, Lucchi NW, Udhayakumar V, Halsey ES, Ratsimbasoa CA;;;;;;
Africa;Madagascar;Matanga;-23.5251;47.5541;Matanga|Madagascar;2018;2018;WT;Sensitive;50;50;100;34732201;Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.;Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.;Dentinger CM, Rakotomanga TA, Rakotondrandriana A, Rakotoarisoa A, Rason MA, Moriarty LF, Steinhardt LC, Kapesa L, Razafindrakoto J, Svigel SS, Lucchi NW, Udhayakumar V, Halsey ES, Ratsimbasoa CA;;;;;;
Africa;DRC;Fungurume;-10.6152;26.325;Fungurume;2018;2019;A557S;Other NS;1;58;1.72;33706773;2021;Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.;Yobi DM, Kayiba NK, Mvumbi DM, Boreux R, Kabututu PZ, Situakibanza HNT, Umesumbu SE, De Mol P, Speybroeck N, Mvumbi GL, Hayette MP;;;;;;
Africa;DRC;Fungurume;-10.6152;26.325;Fungurume;2018;2019;WT;Sensitive;57;58;98.28;33706773;2021;Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.;Yobi DM, Kayiba NK, Mvumbi DM, Boreux R, Kabututu PZ, Situakibanza HNT, Umesumbu SE, De Mol P, Speybroeck N, Mvumbi GL, Hayette MP;;;;;;
Africa;DRC;Fungurume;-10.6152;26.325;Fungurume;2018;2019;WT;Sensitive;57;58;98.28;33706773;2021;Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.;;;;;;;
Africa;DRC;Kabondo;0.515363;25.2202;Kabondo;2018;2019;WT;Sensitive;17;17;100;33706773;2021;Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.;;;;;;;
Africa;DRC;Katana;-2.22502;28.8314;Katana;2018;2019;WT;Sensitive;84;86;97.67;33706773;2021;Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.;;;;;;;
Africa;DRC;Kingasani;-4.40679;15.4107;Kingasani;2018;2019;WT;Sensitive;78;80;97.5;33706773;2021;Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.;;;;;;;
Africa;Rwanda;Pooled multiple sites;-1.9579;30.1127;Rwanda;2022;2023;R561H;WHO-Validated;19;100;19;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Rwanda;Pooled multiple sites;-1.9579;30.1127;Rwanda;2022;2023;A675V;WHO-Validated;5;100;5;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Rwanda;Pooled multiple sites;-1.9579;30.1127;Rwanda;2022;2023;P574L;WHO-Validated;0.7;100;0.7;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Rwanda;Pooled multiple sites;-1.9579;30.1127;Rwanda;2022;2023;P441L;WHO-Candidate;0.8;100;0.8;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Rwanda;Pooled multiple sites;-1.9579;30.1127;Rwanda;2022;2023;G449A;WHO-Candidate;1;100;1;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Rwanda;Pooled multiple sites;-1.9579;30.1127;Rwanda;2022;2023;C469F;WHO-Candidate;2.7;100;2.7;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Rwanda;Pooled multiple sites;-1.9579;30.1127;Rwanda;2022;2023;WT;Sensitive;70.8;100;100;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Rwanda;Nyamagabe;-2.500313494;29.35098941;Nyamagabe;2022;2023;A675V;WHO-Validated;8.8;100;8.8;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Rwanda;Kibingo;-2.223176141;29.77747023;Kibingo;2022;2023;R561H;WHO-Validated;54.5;100;54.5;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Tanzania;Rwenkende;-1.198632792;30.64728862;Rwenkende;2022;2023;R561H;WHO-Validated;12.1;100;12.1;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Tanzania;Pooled multiple sites;-2.5164;32.9175;Tanzania;2022;2023;R561H;WHO-Validated;0.1;100;0.1;;;Preprint;2024;High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing;Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, Tharcisse Munyaneza, Felicien Maisha, Fred Mwebembezi, Rule Budodo, Alec Leonetti, Rebecca Crudale, Vincent Iradukunda, Ntwari Jean Bosco, Ross M. Boyce, Celine I. Mandara, Grace K. Kanyankole, Edgar Mulogo, Deus S. Ishengoma, Stan Hangi, Corine Karema, Jean-Baptiste Mazarati, Jonathan J Juliano, Jeffrey A. Bailey;;;;
Africa;Uganda;Kitgum and Pader in Northern Uganda (Acholi);3.05719144;32.93083689;Acholi;;2017;C469Y;WHO-Validated;17;50;34;;;39136465;2024;A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda;"Ogwang, Rodney; Osoti, Victor; Wamae, Kevin; Ndwiga, Leonard; Muteru, Kelvin; Ningwa, Albert; Tuju, James; Kinyanjui, Sam; Osier, Faith; Marsh, Kevin; Bejon, Philip; Idro, Richard; Ochola-Oyier, Lynette Isabella";;;;
Africa;Uganda;Kitgum and Pader in Northern Uganda (Acholi);3.05719144;32.93083689;Acholi;2016;2017;E507G;Other NS;2;50;4;;;39136465;2024;A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda;"Ogwang, Rodney; Osoti, Victor; Wamae, Kevin; Ndwiga, Leonard; Muteru, Kelvin; Ningwa, Albert; Tuju, James; Kinyanjui, Sam; Osier, Faith; Marsh, Kevin; Bejon, Philip; Idro, Richard; Ochola-Oyier, Lynette Isabella";;;;
Africa;Uganda;Kitgum and Pader in Northern Uganda (Acholi);3.05719144;32.93083689;Acholi;2016;2017;A578S;Widespread other;2;50;4;;;39136465;2024;A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda;"Ogwang, Rodney; Osoti, Victor; Wamae, Kevin; Ndwiga, Leonard; Muteru, Kelvin; Ningwa, Albert; Tuju, James; Kinyanjui, Sam; Osier, Faith; Marsh, Kevin; Bejon, Philip; Idro, Richard; Ochola-Oyier, Lynette Isabella";;;;
Africa;Uganda;Kitgum and Pader in Northern Uganda (Acholi);3.05719144;32.93083689;Acholi;2016;2017;WT;Sensitive;48;50;96;;;39136465;2024;A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda;"Ogwang, Rodney; Osoti, Victor; Wamae, Kevin; Ndwiga, Leonard; Muteru, Kelvin; Ningwa, Albert; Tuju, James; Kinyanjui, Sam; Osier, Faith; Marsh, Kevin; Bejon, Philip; Idro, Richard; Ochola-Oyier, Lynette Isabella";;;;
Africa;Somalia;Afgoi and Balad;2.143163169;45.11692954;Afgoi and Balad;2018;2018;WT;Sensitive;84;84;100;;;37170467;2023;Monitoring antimalarial drug-resistance markers in Somalia;Abdifatah Abdullahi Jalei, Kesara Na-Bangchang, Phunuch Muhamad, and Wanna Chaijaroenkul;;;;
Africa;Somalia;Bosaso;11.27626909;49.18770044;Bosaso;2016;2017;R622I;WHO-Validated;1;138;0.7;;;31296223;2018;High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia;Marian Warsame, Abdillahi Mohamed Hassan, Abdikarim Hussein Hassan, Ali Mohamed Jibril, Nimol Khim, Abdulkadir Mohamed Arale, Ahamed Hassan Gomey, Zainab Said Nur, Said Mohamed Osman, Marian Said Mohamed, Ali Abdulrahman, Fahmi Essa Yusuf, Jamal Ghilan Hefzullah Amran, Benoit Witkowski, Pascal RingwaldMarian Warsame, Abdillahi Mohamed Hassan, Abdikarim Hussein Hassan, Ali Mohamed Jibril, Nimol Khim, Abdulkadir Mohamed Arale, Ahamed Hassan Gomey, Zainab Said Nur, Said Mohamed Osman, Marian Said Mohamed, Ali Abdulrahman, Fahmi Essa Yusuf, Jamal Ghilan Hefzullah Amran, Benoit Witkowski, Pascal Ringwald;;;;
Africa;Somalia;Jowhar;2.78065183;45.5024748;Jowhar;2016;2017;WT;Sensitive;159;159;100;;;31296223;2019;High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in SomaliaHigh therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia;Marian Warsame, Abdillahi Mohamed Hassan, Abdikarim Hussein Hassan, Ali Mohamed Jibril, Nimol Khim, Abdulkadir Mohamed Arale, Ahamed Hassan Gomey, Zainab Said Nur, Said Mohamed Osman, Marian Said Mohamed, Ali Abdulrahman, Fahmi Essa Yusuf, Jamal Ghilan Hefzullah Amran, Benoit Witkowski, Pascal Ringwald;;;;
Africa;Somalia;Bosaso;11.27626909;49.18770044;Bosaso;2016;2017;WT;Sensitive;87;138;99.3;;;31296223;2019;High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia;Marian Warsame, Abdillahi Mohamed Hassan, Abdikarim Hussein Hassan, Ali Mohamed Jibril, Nimol Khim, Abdulkadir Mohamed Arale, Ahamed Hassan Gomey, Zainab Said Nur, Said Mohamed Osman, Marian Said Mohamed, Ali Abdulrahman, Fahmi Essa Yusuf, Jamal Ghilan Hefzullah Amran, Benoit Witkowski, Pascal Ringwald;;;;
